David S. Cooper, MD
Cooper DS. Subclinical Thyroid Disease: A Clinician's Perspective. Ann Intern Med. 1998;129:135-138. doi: 10.7326/0003-4819-129-2-199807150-00016
Download citation file:
Published: Ann Intern Med. 1998;129(2):135-138.
Every clinician knows the symptoms, signs, and laboratory abnormalities associated with overt hyperthyroidism and hypothyroidism. Both conditions are unequivocally associated with morbidity and, occasionally, mortality, and no one would dispute the importance of timely diagnosis and therapy. In contrast, subclinical hyperthyroidism and hypothyroidism have subtle clinical manifestations at most, and the importance of timely diagnosis and treatment continue to be contentious subjects of research studies, position papers, and editorials. The central issues are whether subclinical thyroid diseases are of sufficient clinical importance to warrant screening or case finding and whether, once these conditions are detected by an abnormal serum thyrotropin value and confirmed by further testing, therapy is justified. Because reliable thyroid-stimulating hormone (TSH) assays have been available for almost 20 years, one would think that adequate data would have been amassed by now to answer these questions definitively. However, this is not the case, and we continue to rely on small clinical studies, epidemiologic data, computer simulations , and clinical impressions rather than the results of large randomized clinical trials.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only